Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.7%

2 terminated/withdrawn out of 73 trials

Success Rate

95.1%

+8.6% vs industry average

Late-Stage Pipeline

10%

7 trials in Phase 3/4

Results Transparency

3%

1 of 39 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment Performance

Analytics

N/A
53(80.3%)
Phase 4
5(7.6%)
Phase 1
3(4.5%)
Phase 2
2(3.0%)
Phase 3
2(3.0%)
Early Phase 1
1(1.5%)
66Total
N/A(53)
Phase 4(5)
Phase 1(3)
Phase 2(2)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (73)

Showing 20 of 73 trials
NCT06426550Not ApplicableCompleted

Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV

Role: lead

NCT06705777Phase 4Completed

Randomized Study of Oral Aesculus Hippocastanum and Combinations in Hemorrhoidal Disease After 60 Days of Treatment

Role: collaborator

NCT07063706Not ApplicableCompleted

Pharmaceutical Care for Patients Using Capecitabine

Role: collaborator

NCT06967649Not ApplicableEnrolling By Invitation

Prospective Longitudinal Clinical Study for the Evaluation of Peri-implant Tissue and Osseointegration After Rehabilitation With Osseointegrated Implants

Role: lead

NCT06917131Not ApplicableRecruiting

Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

Role: lead

NCT06912997Not ApplicableActive Not Recruiting

Effects of Inspiratory Muscle Training on Parkinson's Disease

Role: lead

NCT06394557Not ApplicableActive Not Recruiting

Evaluation of In-office Bleaching-induced Sensitivity With 2 or 7 Days Interval Between Sessions

Role: lead

NCT06438445Not ApplicableRecruiting

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Role: lead

NCT06183307Not ApplicableRecruiting

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

Role: lead

NCT06286748Not ApplicableRecruiting

Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients

Role: lead

NCT06288204Not ApplicableRecruiting

Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease

Role: lead

NCT04568161Not ApplicableCompleted

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Role: collaborator

NCT03343184Not ApplicableActive Not Recruiting

Clinical Evaluation of Bulk Fill Composite Restorations Associated to Universal Adhesive System

Role: lead

NCT05183737Not ApplicableActive Not Recruiting

Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease

Role: lead

NCT03244124Not ApplicableActive Not Recruiting

Different Application Strategies When Using Futurabond Universal in Class V Cavities

Role: lead

NCT03924830Not ApplicableActive Not Recruiting

Influence of Surface Sealants on the Quality of Posterior Restorations With Bulk Fill Composites

Role: lead

NCT06394544Not ApplicableNot Yet Recruiting

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

Role: lead

NCT04608903Not ApplicableActive Not Recruiting

Effects of Sulforaphane for Patients With Chronic Kidney Disease

Role: lead

NCT06394531Not ApplicableNot Yet Recruiting

Effects of Jaboticaba (Plinia Cauliflora) Supplementation in Chronic Kidney Disease Patients

Role: lead

NCT05544513Phase 2Active Not Recruiting

Oral Iron Supplementation for Patients With Chronic Kidney Disease

Role: lead